Outcomes After Sirolimus- and Paclitaxel-Eluting Stent Implantation in Patients With Insulin-Treated Diabetes Mellitus

American Journal of Cardiology

Volumn 101, Issue 9, 2008, Pages 1253-1258

  Buch, Ashesh N ^a   Javaid, Aamir ^a   Steinberg, Daniel H ^a   Roy, Probal ^a   Pinto Slottow, Tina L ^a   Xue, Zhenyi ^a   Smith, Kimberly ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HUMAN; INSULIN TREATMENT; KAPLAN MEIER METHOD; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGISTER; THROMBOSIS;

BLOOD VESSEL PROSTHESIS IMPLANTATION; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; HUMANS; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 43049132455     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.12.021     Document Type: Article

References (19)

1. BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularisation Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35 (2000) 1122-1129
2. Niles N.W., McGrath P.D., Malenka D., Quinton H., Wennberg D., Shubrooks S.J., Tryzelaar J.F., Clough R., Hearne M.J., Hernandez Jr. F., Watkins M.W., and O'Connor G.T. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularisation: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 37 (2001) 1008-1015
3. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., and Russell M.E. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
4. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., and Kuntz R.E. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
5. Yang T.H., Park S.W., Hong M.K., Park D.W., Park K.M., Kim Y.H., Han K.H., Lee C.W., Cheong S.S., Kim J.J., and Park S.J. Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. Am J Cardiol 96 (2005) 1389-1392
6. Stankovic G., Cosgrave J., Chieffo A., Iakovou I., Sangiorgi G., Montorfano M., Airoldi F., Carlino M., Michev I., Finci L., and Colombo A. Impact of sirolimus-eluting and paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery. Am J Cardiol 98 (2006) 362-366
7. Moussa I., Leon M.B., Baim D.S., O'Neill W.W., Popma J.J., Buchbinder M., Midwall J., Simonton C.A., Keim E., Wang P., Kuntz R.E., and Moses J.W. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109 (2004) 2273-2278
8. Hermiller J.B., Raizner A., Cannon L., Gurbel P.A., Kutcher M.A., Wong S.C., Russell M.E., Ellis S.G., Mehran R., and Stone G.W. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1172-1179
9. Ong A.T., Aoki J., van Mieghem C.A., Rodriguez Granillo G.A., Valgimigli M., Tsuchida K., Sonnenschein K., Regar E., van der Giessen W.J., de Jaegere P.P., et al. Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries). Am J Cardiol 96 (2005) 358-362
10. Corpus R.A., George P.B., House J.A., Dixon S.R., Ajluni S.C., Devlin W.H., Timmis G.C., Balasubramaniam M., and O'Neill W.W. Optimal glycemic control is associated with a lower rate of target vessel revascularisation in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43 (2004) 8-14
11. Seabra-Gomes R. Percutaneous coronary interventions with drug eluting stents for diabetic patients. Heart 92 (2006) 410-419
12. Schuhlen H., Kastrati A., Dirschinger J., Hausleiter J., Elezi S., Wehinger A., Pache J., Hadamitzky M., and Schomig A. Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation 98 (1998) 104-111
13. Kuchulakanti P.K., Chu W.W., Torguson R., Ohlmann P., Rha S.W., Clavijo L.C., Kim S.W., Bui A., Gevorkian N., Xue Z., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
14. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
15. Mintz G.M., and Weissman N.J. Intravascular ultrasound in the drug-eluting stent era. J Am Coll Cardiol 48 (2006) 421-429
16. King III S.B., Lembo N.J., Weintraub W.S., Kosinski A.S., Barnhart H.X., Kutner M.H., Alazraki N.P., Guyton R.A., and Zhao X.Q. A randomised trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 331 (1994) 1044-1050
17. Serruys P.W., Ong A.T., van Herwerden L.A., Sousa J.E., Jatene A., Bonnier J.J., Schonberger J.P., Buller N., Bonser R., Disco C., et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularisation Therapies Study (ARTS) randomised trial. J Am Coll Cardiol 46 (2005) 575-581
18. Morice M.C., Colombo A., Meier B., Serruys P., Tamburino C., Guagliumi G., Sousa E., and Stoll H.P. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomised controlled trial. JAMA 295 (2006) 895-904
19. Dibra A., Kastrati A., Mehilli J., Pache J., Schuhlen H., von Beckerath N., Ulm K., Wessely R., Dirschinger J., and Schomig A. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670